Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 4
2009 4
2010 1
2011 1
2012 3
2013 6
2014 2
2015 6
2016 6
2017 7
2018 9
2019 13
2020 8
2021 13
2022 10
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Proteasome inhibitors as anticancer agents.
Gazzaroli G, Angeli A, Giacomini A, Ronca R. Gazzaroli G, et al. Among authors: ronca r. Expert Opin Ther Pat. 2023 Nov;33(11):775-796. doi: 10.1080/13543776.2023.2272648. Epub 2024 Jan 11. Expert Opin Ther Pat. 2023. PMID: 37847492 Review.
TGF-β mediated drug resistance in solid cancer.
Turati M, Mousset A, Issa N, Turtoi A, Ronca R. Turati M, et al. Among authors: ronca r. Cytokine Growth Factor Rev. 2023 Jun-Aug;71-72:54-65. doi: 10.1016/j.cytogfr.2023.04.001. Epub 2023 Apr 11. Cytokine Growth Factor Rev. 2023. PMID: 37100675 Review.
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer.
Giacomini A, Turati M, Grillo E, Rezzola S, Ghedini GC, Schuind AC, Foglio E, Maccarinelli F, Faletti J, Filiberti S, Chambery A, Valletta M, Melocchi L, Gofflot S, Chiavarina B, Turtoi A, Presta M, Ronca R. Giacomini A, et al. Among authors: ronca r. Exp Hematol Oncol. 2023 Sep 25;12(1):82. doi: 10.1186/s40164-023-00441-y. Exp Hematol Oncol. 2023. PMID: 37749607 Free PMC article.
Future applications of FGF/FGFR inhibitors in cancer.
Ghedini GC, Ronca R, Presta M, Giacomini A. Ghedini GC, et al. Among authors: ronca r. Expert Rev Anticancer Ther. 2018 Sep;18(9):861-872. doi: 10.1080/14737140.2018.1491795. Epub 2018 Jul 2. Expert Rev Anticancer Ther. 2018. PMID: 29936878 Review.
Ten Years of CRISPRing Cancers In Vitro.
Capoferri D, Filiberti S, Faletti J, Tavani C, Ronca R. Capoferri D, et al. Among authors: ronca r. Cancers (Basel). 2022 Nov 23;14(23):5746. doi: 10.3390/cancers14235746. Cancers (Basel). 2022. PMID: 36497228 Free PMC article. Review.
The FGF/FGFR system in the physiopathology of the prostate gland.
Giacomini A, Grillo E, Rezzola S, Ribatti D, Rusnati M, Ronca R, Presta M. Giacomini A, et al. Among authors: ronca r. Physiol Rev. 2021 Apr 1;101(2):569-610. doi: 10.1152/physrev.00005.2020. Epub 2020 Jul 30. Physiol Rev. 2021. PMID: 32730114 Free article. Review.
Circulating microRNAs and Their Role in Multiple Myeloma.
Federico C, Sacco A, Belotti A, Ribolla R, Cancelli V, Giacomini A, Ronca R, Chiarini M, Imberti L, Marini M, Rossi G, Presta M, Paiva B, Roccaro AM. Federico C, et al. Among authors: ronca r. Noncoding RNA. 2019 May 2;5(2):37. doi: 10.3390/ncrna5020037. Noncoding RNA. 2019. PMID: 31052608 Free PMC article. Review.
FGF-trapping hampers cancer stem-like cells in uveal melanoma.
Loda A, Calza S, Giacomini A, Ravelli C, Krishna Chandran AM, Tobia C, Tabellini G, Parolini S, Semeraro F, Ronca R, Rezzola S. Loda A, et al. Among authors: ronca r. Cancer Cell Int. 2023 May 11;23(1):89. doi: 10.1186/s12935-023-02903-z. Cancer Cell Int. 2023. PMID: 37165394 Free PMC article.
100 results